LLAI — LungLife AI Cashflow Statement
0.000.00%
Last trade - 00:00- £8.58m
- £6.60m
- $0.05m
Annual cashflow statement for LungLife AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | PRESS |
| Standards: | — | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -4.84 | -7.44 | -7.61 | -5.41 |
| Depreciation | ||||
| Non-Cash Items | 1 | 0.588 | 1.1 | 0.011 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.68 | -1.01 | 0.375 | 0.128 |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -2.87 | -7.54 | -5.84 | -5.02 |
| Capital Expenditures | -0.005 | -1.85 | -0.085 | -0.077 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0 | -5.36 | -0.03 | 5.03 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.005 | -7.21 | -0.115 | 4.95 |
| Financing Cash Flow Items | -0.006 | -1.1 | 0.036 | -0.041 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2.28 | 23.8 | -0.169 | -0.296 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.599 | 9.09 | -6.13 | -0.364 |